✦ LIBER ✦

Autolymphocyte Therapy: III. Effective Adjuvant Adoptive Cellular Therapy with in Vivo Anti-tumor Specificity against Murine Melanoma and Carcinoma Using ex-Vivo-Activated Memory T-Lymphocytes

✍ Scribed by Jay E. Gold; T.R. Masters; Michael E. Osband

Book ID: 117979596
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 460 KB
Volume: 59
Category: Article
ISSN: 0022-4804
DOI: 10.1006/jsre.1995.1165

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autolymphocyte Therapy: II. Dependence o

Autolymphocyte Therapy: II. Dependence of in Vivo Anti-tumor Specificity and Long-Term Immunity against Murine Melanoma and Carcinoma on ex Vivo Activated Donor Memory T-Cells

✍ Jay E. Gold; Michael E. Osband 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 486 KB

Volume 59, Number 2 (1995), “Autolymphoc

Volume 59, Number 2 (1995), “Autolymphocyte Therapy. III. Effective Adjuvant Adoptive Cellular Therapy within VivoAnti-tumor Specificity against Murine Melanoma and Carcinoma Usingex-Vivo-Activated Memory T-Lymphocytes,” by Jay E. Gold, T. R. Masters, and Michael E. Osband, pages 279–286;

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 18 KB

Adoptively Transferred ex Vivo Activated

Adoptively Transferred ex Vivo Activated Memory T Cells with Cyclophosphamide: Effective Tumor-Specific Chemoimmunotherapy of Advanced Metastatic Murine Melanoma and Carcinoma

✍ Jay E. Gold; David T. Zachary; Michael E. Osband 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 493 KB

Adoptive cellular therapy of human breas

Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II)

✍ Dr. Jay E. Gold; Ira J. Bleiweiss; Alisan B. Goldfarb; Joel J. Bauer; Irwin M. G 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

Autolymphocyte therapy (ALT) is adoptive cellular therapy of cancer using ex vivo activation of autologous peripheral blood lymphocytes (PBL). Memory T cells are the principal effector population in ALT, with in vivo activity in patients with metastatic renal cell carcinoma (RCC) and melanoma, and e

Adoptive transfer of ex vivo-activated m

Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma

✍ Jay E. Gold; David T. Zachary; Michael E. Osband 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 850 KB

Autolymphocyte therapy (ALT) is adoptive cellular therapy of neoplastic disease using ex vivo activation of autologous (human) or syngeneic (murine) lymphocytes from tumor-bearing hosts (TBH) by low doses of anti-CD3 monoclonal antibody (MAb) and a mixture of previously prepared autologous cytokines